however, the labeling for sitagliptin recommends appropriate monitoring and does not suggest dosage adjustments to either sitagliptin or digoxin
DOI: Published online: April 1, 2024 Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang, China Corresponding authors: Guoyue Yuan Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China E-mail: [email protected] Xia Deng Department of Endocrinology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China E-mail: [email protected] Copyright 2024 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
A calendar app works better
Oral semaglutide (Rybelsus) is the only FDA-approved oral GLP-1 receptor agonist
Ans: Safety in pregnant or breeding pets has not been established
: , ,